N-(2-AMINO-4-CHLORO-3-METHYLPHENYL)-1-(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)BENZOYL)-2-METHYL-2-PYRROLIDINECARBOXAMIDE, (2S)-
UNII XB6P8JF4DQ

Substance Identification & Data

This profile provides standardized clinical and technical data for N-(2-amino-4-chloro-3-methylphenyl)-1-(5-methoxy-2-(2h-1,2,3-triazol-2-yl)benzoyl)-2-methyl-2-pyrrolidinecarboxamide, (2s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XB6P8JF4DQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2248726-40-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XB6P8JF4DQ

CAS Registry Number

2248726-40-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-(2-AMINO-4-CHLORO-3-METHYLPHENYL)-1-(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)BENZOYL)-2-METHYL-2-PYRROLIDINECARBOXAMIDE, (2S)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H25ClN6O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VGRWKWJHIVFHIF-QHCPKHFHSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

135371990

Unique identification number in the NCBI database of chemical substances.

Substance Type

N-(2-Amino-4-chloro-3-methylphenyl)-1-[5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoyl]-2-methyl-2-pyrrolidinecarboxamide, (2S)-

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1c(ccc(c1N)NC(=O)[C@]2(C)CCCN2C(=O)c3cc(ccc3-n4nccn4)OC)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-(2-amino-4-chloro-3-methylphenyl)-1-(5-methoxy-2-(2h-1,2,3-triazol-2-yl)benzoyl)-2-methyl-2-pyrrolidinecarboxamide, (2s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.